ERBB2 and breast cancer: In these models, we tested both clinical-grade pertuzumab and the murine version of pertuzumab with the functionally equivalent mouse isotype (2C4-IgG2A) to demonstrate the different MOA of pertuzumab in treating HER2+ BC.